Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stewart A Factor

Showing results (11-20 of 198) with videos related to

Pageof 20
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 25, 2013
Editorial: Neurotherapeutics of movement disordersStewart A Factor, Joseph Jankovic
Neurology|October 8, 2014
Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraineStewart A Factor, Joseph Jankovic
Parkinsonism & Related Disorders|May 2, 2013
Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesiaMichael Silver, Stewart A Factor
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 22, 2013
Promise of pharmacogenomics for drug discovery, treatment and prevention of Parkinson's disease. A perspectiveHaydeh Payami, Stewart A Factor
Neurology|July 14, 2017
Phosphodiesterase 4: Rethinking cognition in Parkinson diseaseClaudia Jacova, Stewart A Factor
Neurologic Clinics|November 30, 2014
Diagnosis and treatment of dystoniaH A Jinnah, Stewart A Factor
Clinical Parkinsonism & Related Disorders|July 28, 2025
Paroxysmal abdominalgia as a non-motor wearing off phenomenon in Parkinson's disease. A case series and literature reviewAbdalmalik Bin Khunayfir, Stewart A Factor
Journal of the Neurological Sciences|February 14, 2018
VMAT2 inhibitors for the treatment of tardive dyskinesiaLaura M Scorr, Stewart A Factor
Current Neurology and Neuroscience Reports|April 21, 2011
Of monkeys and men: analysis of the phase 2 double-blind, sham-surgery controlled, randomized trial of AAV2-neurturin gene therapy for Parkinson's diseaseDaniel E Huddleston, Stewart A Factor
Clinical Neuropharmacology|December 17, 2004
Threatening auditory hallucinations and Cotard syndrome in Parkinson diseaseStewart A Factor, Eric S Molho
Pageof 20

Showing results (11-20 of 198) with videos related to

Sort By:
Pageof 20
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 25, 2013
Editorial: Neurotherapeutics of movement disordersStewart A Factor, Joseph Jankovic
Neurology|October 8, 2014
Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraineStewart A Factor, Joseph Jankovic
Parkinsonism & Related Disorders|May 2, 2013
Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesiaMichael Silver, Stewart A Factor
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 22, 2013
Promise of pharmacogenomics for drug discovery, treatment and prevention of Parkinson's disease. A perspectiveHaydeh Payami, Stewart A Factor
Neurology|July 14, 2017
Phosphodiesterase 4: Rethinking cognition in Parkinson diseaseClaudia Jacova, Stewart A Factor
Neurologic Clinics|November 30, 2014
Diagnosis and treatment of dystoniaH A Jinnah, Stewart A Factor
Clinical Parkinsonism & Related Disorders|July 28, 2025
Paroxysmal abdominalgia as a non-motor wearing off phenomenon in Parkinson's disease. A case series and literature reviewAbdalmalik Bin Khunayfir, Stewart A Factor
Journal of the Neurological Sciences|February 14, 2018
VMAT2 inhibitors for the treatment of tardive dyskinesiaLaura M Scorr, Stewart A Factor
Current Neurology and Neuroscience Reports|April 21, 2011
Of monkeys and men: analysis of the phase 2 double-blind, sham-surgery controlled, randomized trial of AAV2-neurturin gene therapy for Parkinson's diseaseDaniel E Huddleston, Stewart A Factor
Clinical Neuropharmacology|December 17, 2004
Threatening auditory hallucinations and Cotard syndrome in Parkinson diseaseStewart A Factor, Eric S Molho
Pageof 20